Table 1

Clinical and hematologic features of investigated patients

PNH patientSex/age, yTime since diagnosis, yHemoglobin level, g/LWBC, × 109/LANC, × 109/LLymphocyte count, × 109/LPlatelet count, × 109/LReticulocytes, %Size of PNH cell population,* %
ThrombosisBlood transfusionOther treatment
RBCPMN
M/53 102 4.4 3.2 0.9 249 6.0 21 81 No Occasional Supportive 
M/45 94 2.9 1.6 1.1 97 4.8 20 55 No Never Supportive 
M/34 101 4.7 2.5 1.7 178 10.2 50 80 No Occasional Supportive 
F/54 10 81 3.3 2.4 0.7 57 7.1 36 98 Hepatoportal Never Supportive 
F/54 10 77 3.8 1.8 1.5 193 6.4 30 93 No Never Supportive 
M/33 123 2.1 0.9 0.9 87 2.2 22 69 No Never Supportive 
F/25 67 2.5 1.1 1.2 83 14.5 23 82 No Regular Supportive§ 
F/53 121 3.6 1.6 1.7 64 2.1 51 96 Budd-Chiari Occasional Supportive 
F/25 109 4.5 2.4 1.8 323 9.8 26 80 No Never Supportive 
10 F/45 86 8.7 7.5 1.0 143 17.0 75 99 No Occasional Supportive 
11 M/33 101 5.6 3.3 1.8 262 6.8 37 97 No Occasional Supportive§ 
12 F/55 23 84 3.9 2.5 1.0 185 10.1 54 90 No Regular Supportive 
13 F/32 78 4.0 2.2 1.3 193 2.4 91 69 No Occasional Supportive§ 
14 M/41 82 4.6 2.7 1.5 20 2.5 24 93 No Regular Supportive 
15 F/46 68 3.7 1.8 1.6 172 4.5 59 91 No Never Supportive 
16 M/25 79 5.0 3.6 1.0 164 14.1 16 84 No Regular Supportive 
17 M/38 78 7.0 6.3 0.6 327 9.5 83 99 No Regular Supportive§ 
18 M/36 82 5.3 3.8 1.2 252 8.5 83 97 No Occasional Supportive 
19 M/65 112 7.7 6.7 0.8 203 6.7 35 67 No Occasional Supportive 
20 F/46 98 4.3 3.4 0.5 240 19.7 28 89 No Regular Supportive 
PNH patientSex/age, yTime since diagnosis, yHemoglobin level, g/LWBC, × 109/LANC, × 109/LLymphocyte count, × 109/LPlatelet count, × 109/LReticulocytes, %Size of PNH cell population,* %
ThrombosisBlood transfusionOther treatment
RBCPMN
M/53 102 4.4 3.2 0.9 249 6.0 21 81 No Occasional Supportive 
M/45 94 2.9 1.6 1.1 97 4.8 20 55 No Never Supportive 
M/34 101 4.7 2.5 1.7 178 10.2 50 80 No Occasional Supportive 
F/54 10 81 3.3 2.4 0.7 57 7.1 36 98 Hepatoportal Never Supportive 
F/54 10 77 3.8 1.8 1.5 193 6.4 30 93 No Never Supportive 
M/33 123 2.1 0.9 0.9 87 2.2 22 69 No Never Supportive 
F/25 67 2.5 1.1 1.2 83 14.5 23 82 No Regular Supportive§ 
F/53 121 3.6 1.6 1.7 64 2.1 51 96 Budd-Chiari Occasional Supportive 
F/25 109 4.5 2.4 1.8 323 9.8 26 80 No Never Supportive 
10 F/45 86 8.7 7.5 1.0 143 17.0 75 99 No Occasional Supportive 
11 M/33 101 5.6 3.3 1.8 262 6.8 37 97 No Occasional Supportive§ 
12 F/55 23 84 3.9 2.5 1.0 185 10.1 54 90 No Regular Supportive 
13 F/32 78 4.0 2.2 1.3 193 2.4 91 69 No Occasional Supportive§ 
14 M/41 82 4.6 2.7 1.5 20 2.5 24 93 No Regular Supportive 
15 F/46 68 3.7 1.8 1.6 172 4.5 59 91 No Never Supportive 
16 M/25 79 5.0 3.6 1.0 164 14.1 16 84 No Regular Supportive 
17 M/38 78 7.0 6.3 0.6 327 9.5 83 99 No Regular Supportive§ 
18 M/36 82 5.3 3.8 1.2 252 8.5 83 97 No Occasional Supportive 
19 M/65 112 7.7 6.7 0.8 203 6.7 35 67 No Occasional Supportive 
20 F/46 98 4.3 3.4 0.5 240 19.7 28 89 No Regular Supportive 

All patients experienced recurrent episodes of hemoglobinuria.

WBC indicates white blood count; ANC, absolute neutrophil count; RBC, red blood cells; PMN, granulocytes.

*

The percentage of PNH PMN reflects the relative size of the PNH cell population more accurately than the percentage of PNH RBC because the latter will be grossly underestimated as a consequence of selective hemolysis; this may be further complicated by blood transfusion.

Previous prednisone treatment.

Recurrent attacks of severe abdominal pain but no documented thrombosis.

§

Previous antithymocyte globulin treatment.

Close Modal

or Create an Account

Close Modal
Close Modal